GITNUX MARKETDATA REPORT 2024
Renal Denervation Industry Statistics
The global renal denervation market is expected to witness significant growth due to increasing prevalence of hypertension and rise in demand for minimally invasive procedures for treatment.
In this post, we will explore key statistics and trends in the renal denervation industry, shedding light on its market size, projected growth, major players, regional dynamics, technological advancements, and impact of external factors such as the COVID-19 pandemic. With valuable insights into the current landscape and future prospects, let’s delve into the data driving the renal denervation market forward.
Statistic 1
"The Global Renal Denervation Market size was valued at USD 34.3 million in 2020."
Statistic 2
"It is projected that the market will reach USD 65.5 million by 2027."
Statistic 3
"The Renal Denervation Industry is expected to grow at a CAGR of 36.4% from 2021 to 2027."
Statistic 4
"In 2018, North America accounted for the highest share of the renal denervation industry."
Statistic 5
"There are several key players in the renal denervation market including Medtronic, Replay Therapeutics, and Ablative Solutions."
Statistic 6
"Europe is expected to show high growth potential in the renal denervation market due to the prevalence of uncontrolled hypertension."
Statistic 7
"In 2018, Medtronic held the leading position in the global market."
Statistic 8
"Nearly 1 billion people globally suffer from hypertension, driving the demand for renal denervation procedures."
Statistic 9
"The advent of advanced technologies in the renal denervation process should drive large positive market growth from 2021 to 2027."
Statistic 10
"By end user, the hospital segment dominated the global renal denervation market in 2019."
Statistic 11
"Amid the COVID-19 pandemic, the market experienced a temporary dip in 2020 due to postponed and cancelled elective surgeries."
Statistic 12
"Over the forecast period, the ablation segment is likely to grow rapidly based on procedure type."
Statistic 13
"The market in Asia Pacific is projected to expand at a CAGR of 36% over the forecast timeframe."
Statistic 14
"The increasing prevalence of drug-resistant hypertension will propel the market growth of renal denervation."
Statistic 15
"The radiofrequency sector overtook the ultrasound and other renal denervation devices with more than 75% of the market share."
Statistic 16
"The lack of awareness among patients about renal denervation as a viable treatment option for hypertension curbs the market growth."
Statistic 17
"In terms of product, the Symplicity Renal Denervation System is expected to dominate the renal denervation market."